688799 华纳药厂
已收盘 02-13 15:00:01
资讯
新帖
简况
每周股票复盘:华纳药厂(688799)2025年净利增46.95%
证券之星 · 02-15
每周股票复盘:华纳药厂(688799)2025年净利增46.95%
华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%
智通财经 · 02-13
华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%
华纳药厂(688799.SH)参与国家组织集采药品协议期满品种接续采购拟中选
智通财经网 · 02-12
华纳药厂(688799.SH)参与国家组织集采药品协议期满品种接续采购拟中选
每周股票复盘:华纳药厂(688799)ZG-002片Ⅰ期临床研究完成
证券之星 · 02-08
每周股票复盘:华纳药厂(688799)ZG-002片Ⅰ期临床研究完成
华纳药厂(688799.SH)参股公司收到ZG-002片Ⅰ期临床研究报告
智通财经 · 02-05
华纳药厂(688799.SH)参股公司收到ZG-002片Ⅰ期临床研究报告
华纳药厂(688799)披露关于撤回利多卡因凝胶贴膏药品注册申请的公告,1月27日股价下跌2.8%
证券之星 · 01-27
华纳药厂(688799)披露关于撤回利多卡因凝胶贴膏药品注册申请的公告,1月27日股价下跌2.8%
1月22日华纳药厂涨6.52%,安信医药健康股票A基金重仓该股
证券之星 · 01-22
1月22日华纳药厂涨6.52%,安信医药健康股票A基金重仓该股
【机构调研记录】农银汇理基金调研华纳药厂
证券之星 · 2025-12-31
【机构调研记录】农银汇理基金调研华纳药厂
华纳药厂(688799)披露变更注册资本及公司治理结构调整公告,12月26日股价下跌2.2%
证券之星 · 2025-12-26
华纳药厂(688799)披露变更注册资本及公司治理结构调整公告,12月26日股价下跌2.2%
华纳药厂(688799)披露关于获得药品注册证书的公告,12月25日股价下跌0.2%
证券之星 · 2025-12-25
华纳药厂(688799)披露关于获得药品注册证书的公告,12月25日股价下跌0.2%
华纳药厂最新公告:收到重酒石酸去甲肾上腺素注射液药品注册证书
证券之星 · 2025-12-25
华纳药厂最新公告:收到重酒石酸去甲肾上腺素注射液药品注册证书
华纳药厂(688799)披露关于获得药品注册证书的公告,12月22日股价上涨3.12%
证券之星 · 2025-12-22
华纳药厂(688799)披露关于获得药品注册证书的公告,12月22日股价上涨3.12%
华纳药厂(688799.SH)获得盐酸异丙肾上腺素注射液药品注册证书
智通财经 · 2025-12-22
华纳药厂(688799.SH)获得盐酸异丙肾上腺素注射液药品注册证书
华纳药厂(688799)披露拟变更注册资本及调整董事会人数,12月18日股价下跌0.76%
证券之星 · 2025-12-18
华纳药厂(688799)披露拟变更注册资本及调整董事会人数,12月18日股价下跌0.76%
华纳药厂最新公告:获得硫酸镁钠钾口服用浓溶液药品注册证书
证券之星 · 2025-12-10
华纳药厂最新公告:获得硫酸镁钠钾口服用浓溶液药品注册证书
华纳药厂(688799)披露关于获得药品注册证书的公告,11月28日股价上涨0.62%
证券之星 · 2025-11-28
华纳药厂(688799)披露关于获得药品注册证书的公告,11月28日股价上涨0.62%
华纳药厂(688799.SH):富马酸福莫特罗吸入溶液获药品注册证书
智通财经 · 2025-11-28
华纳药厂(688799.SH):富马酸福莫特罗吸入溶液获药品注册证书
每周股票复盘:华纳药厂(688799)Q3净利增198.16%
证券之星 · 2025-11-02
每周股票复盘:华纳药厂(688799)Q3净利增198.16%
华纳药厂(688799)2025年三季报简析:营收净利润同比双双增长
证券之星 · 2025-11-01
华纳药厂(688799)2025年三季报简析:营收净利润同比双双增长
华纳药厂(688799)9月30日股东户数0.64万户,较上期减少11.83%
证券之星 · 2025-10-31
华纳药厂(688799)9月30日股东户数0.64万户,较上期减少11.83%
公司概况
公司名称:
湖南华纳大药厂股份有限公司
所属行业:
医药制造业
上市日期:
2021-07-13
主营业务:
湖南华纳大药厂股份有限公司的主营业务是化学原料药、化学药制剂和中药制剂的研发、生产与销售。公司的主要产品是制剂、原料药及中间体、植物提取物及食品。2024年,公司凭借持续的科技创新和研发投入,荣获中国证券报颁发的“新质企业金牛奖”、每日经济新闻主办的第十三届中国上市公司峰会“大健康最具成长上市公司”。
发行价格:
30.82
{"stockData":{"symbol":"688799","market":"SH","secType":"STK","nameCN":"华纳药厂","latestPrice":45.33,"timestamp":1770966001000,"preClose":46.5,"halted":0,"volume":2849788,"delay":0,"changeRate":-0.0252,"floatShares":131000000,"shares":131000000,"eps":1.6223,"marketStatus":"已收盘","change":-1.17,"latestTime":"02-13 15:00:01","open":46.6,"high":46.88,"low":45.2,"amount":131000000,"amplitude":0.0361,"askPrice":45.35,"askSize":10,"bidPrice":45.33,"bidSize":45,"shortable":0,"etf":0,"ttmEps":1.6223,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":46.5,"symbolType":"stock_kcb","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":51.15,"lowLimit":41.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":131320000,"isCdr":false,"pbRate":2.99,"roa":"--","peRate":27.941811,"roe":"11.01%","epsLYR":1.75,"committee":-0.306475,"marketValue":5953000000,"turnoverRate":0.0217,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-02-24。","afterMarket":{"amount":0,"volume":0,"close":45.33,"buyVolume":0,"sellVolume":0,"time":1770968037558,"indexStatus":"已收盘 02-13 15:30:00","preClose":46.5},"floatMarketCap":5953000000},"requestUrl":"/m/hq/s/688799/wiki","defaultTab":"wiki","newsList":[{"id":"2611114391","title":"每周股票复盘:华纳药厂(688799)2025年净利增46.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611114391","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611114391?lang=zh_cn&edition=full","pubTime":"2026-02-15 01:31","pubTimestamp":1771090268,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,华纳药厂报收于45.33元,较上周的47.56元下跌4.69%。本周,华纳药厂2月9日盘中最高价报48.23元。华纳药厂当前最新总市值59.53亿元,在化学制药板块市值排名84/150,在两市A股市值排名3090/5189。业绩披露要点业绩快报华纳药厂预计发布2025年年报,归属净利润为2.415亿元,同比增长46.95%。2025年度业绩快报公告2025年度营业总收入为151,559.43万元,同比增长7.26%;营业利润为24,513.09万元,同比增长51.53%;归属于母公司所有者的净利润为24,146.73万元,同比增长46.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2611131320","title":"华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611131320","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611131320?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:10","pubTimestamp":1770970235,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)披露2025年度业绩快报,2025年度实现营业收入15.16亿元,同比增长7.26%;归属于母公司所有者的净利润2.41亿元,同比增长46.95%。报告期内,公司营业收入增长主要系公司制剂产品、原料药及中间体产品销售收入增长以及技术服务收入增长共同所致;归属于母公司所有者的净利润增加主要是受投资收益影响;归属于母公司所有者的扣除非经常性损益的净利润下滑主要是因为计提股权激励费用影响,剔除股权激励费用影响后,归属于母公司所有者的扣除非经常性损益的净利润为1.82亿元,较上年同期增加31.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688799"],"gpt_icon":0},{"id":"2610949043","title":"华纳药厂(688799.SH)参与国家组织集采药品协议期满品种接续采购拟中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2610949043","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610949043?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:51","pubTimestamp":1770889870,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)发布公告,近日,公司参加了国家组织集采药品协议期满品种接续采购办公室组织的国家组织集采药品协议期满品种接续采购。根据接续采购办公室发布的《国家组织集采药品协议期满品种接续采购拟中选结果公示》,公司蒙脱石散等部分药品拟中选本次接续采购。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2609692525","title":"每周股票复盘:华纳药厂(688799)ZG-002片Ⅰ期临床研究完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2609692525","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609692525?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:55","pubTimestamp":1770486913,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,华纳药厂报收于47.56元,较上周的47.3元上涨0.55%。本周,华纳药厂2月6日盘中最高价报48.85元。华纳药厂当前最新总市值62.46亿元,在化学制药板块市值排名83/150,在两市A股市值排名2967/5186。本周关注点公司公告汇总:参股公司ZG-002片Ⅰ期临床研究完成,安全性与耐受性良好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2609216433","title":"华纳药厂(688799.SH)参股公司收到ZG-002片Ⅰ期临床研究报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2609216433","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609216433?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:57","pubTimestamp":1770278225,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂 发布公告,公司参股公司上海致根医药科技有限公司自主研发的ZG-002片在国家药品监督管理局同意下开展Ⅰ期临床试验已于近期完成,并于近期收到临床研究报告。ZG-002是致根医药自主开发的具有全新结构的新型抗自身免疫性疾病的药物,属于1类新药。ZG-002目前拟用于治疗中重度斑块状银屑病。本次临床试验的目的主要是评估ZG-002片在健康成年受试者中的安全性和耐受性、药代动力学特征及食物影响等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4079","688799","BK4548","ZG","BK4551"],"gpt_icon":0},{"id":"2606780054","title":"华纳药厂(688799)披露关于撤回利多卡因凝胶贴膏药品注册申请的公告,1月27日股价下跌2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780054","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606780054?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:25","pubTimestamp":1769523919,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘,华纳药厂报收于47.95元,较前一交易日下跌2.8%,最新总市值为62.97亿元。该股当日开盘49.38元,最高49.45元,最低47.05元,成交额达2.63亿元,换手率为4.2%。湖南华纳大药厂股份有限公司近日收到国家药品监督管理局核准签发的《药品注册申请终止通知书》,同意公司撤回利多卡因凝胶贴膏的注册申请。此次撤回不会对公司当期及未来生产经营与业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700041933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2605468049","title":"1月22日华纳药厂涨6.52%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605468049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605468049?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:35","pubTimestamp":1769067350,"startTime":"0","endTime":"0","summary":"证券之星消息,1月22日华纳药厂涨6.52%,收盘报50.35元,换手率5.77%,成交量7.58万手,成交额3.74亿元。重仓华纳药厂的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为3.62亿元,最新净值1.497,较上一交易日上涨0.6%,近一年上涨74.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200019624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2595745418","title":"【机构调研记录】农银汇理基金调研华纳药厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2595745418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595745418?lang=zh_cn&edition=full","pubTime":"2025-12-31 08:11","pubTimestamp":1767139911,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及12月30日披露的机构调研信息,农银汇理基金近期对1家上市公司进行了调研,相关名单如下:1)华纳药厂 调研纪要:2025年前三季度,公司实现营业收入10.86亿元,同比增长1.55%;实现归属于上市公司股东的净利润2.07亿元,同比增长30.75%。农银汇理基金成立于2008年,截至目前,资产管理规模2197.3亿元,排名36/212;资产管理规模1378.96亿元,排名37/212;管理公募基金数139只,排名58/212;旗下公募基金经理27人,排名50/212。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100008196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2594294781","title":"华纳药厂(688799)披露变更注册资本及公司治理结构调整公告,12月26日股价下跌2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294781","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594294781?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:48","pubTimestamp":1766760496,"startTime":"0","endTime":"0","summary":"近日,湖南华纳大药厂股份有限公司召开2025年第二次临时股东大会,审议通过了关于变更注册资本、取消监事会、调整董事会人数、修订《公司章程》并办理工商变更登记的议案,以及修订公司部分治理制度的相关子议案。北京市康达律师事务所对本次会议进行了见证,并出具法律意见书,确认会议的召集和召开程序、召集人和出席人员资格、表决程序及表决结果均符合相关法律法规及公司章程的规定,会议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799","000860.SH"],"gpt_icon":0},{"id":"2594237029","title":"华纳药厂(688799)披露关于获得药品注册证书的公告,12月25日股价下跌0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594237029","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594237029?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:47","pubTimestamp":1766674038,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘,华纳药厂报收于49.0元,较前一交易日下跌0.2%,最新总市值为64.35亿元。该股当日开盘48.88元,最高49.13元,最低48.06元,成交额达6112.77万元,换手率为0.95%。公司近日发布公告称,湖南华纳大药厂股份有限公司近日收到国家药品监督管理局核准签发的重酒石酸去甲肾上腺素注射液《药品注册证书》,批准该产品注册并发放药品注册证书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2594361432","title":"华纳药厂最新公告:收到重酒石酸去甲肾上腺素注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2594361432","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594361432?lang=zh_cn&edition=full","pubTime":"2025-12-25 18:01","pubTimestamp":1766656877,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司收到国家药品监督管理局核准签发的重酒石酸去甲肾上腺素注射液《药品注册证书》,该药品用于急性低血压状态的血压恢复,也可用于心跳骤停的辅助治疗和心跳骤停复苏后的血压维持。该药品注册证书的取得进一步丰富了公司制剂产品品种,但未来销售情况可能受到政策变化、市场需求、同类型药品市场竞争等多种因素影响,具有不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500027086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2593772433","title":"华纳药厂(688799)披露关于获得药品注册证书的公告,12月22日股价上涨3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593772433","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593772433?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:27","pubTimestamp":1766413638,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘,华纳药厂报收于49.84元,较前一交易日上涨3.12%,最新总市值为65.45亿元。该股当日开盘48.57元,最高50.33元,最低48.13元,成交额达1.24亿元,换手率为1.91%。公司近日发布公告称,湖南华纳大药厂股份有限公司近日收到国家药品监督管理局核准签发的盐酸异丙肾上腺素注射液《药品注册证书》,批准该产品注册并发放药品注册证书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200034758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2593483845","title":"华纳药厂(688799.SH)获得盐酸异丙肾上腺素注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593483845","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593483845?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:10","pubTimestamp":1766394634,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)发布公告,近日,公司收到国家药品监督管理局核准签发的盐酸异丙肾上腺素注射液《药品注册证书》。盐酸异丙肾上腺素注射液用于治疗心源性或感染性休克;治疗完全性房室传导阻滞,心搏骤停。公司盐酸异丙肾上腺素注射液按新注册分类化学药品3类获得药品注册证书,视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华纳药厂(688799.SH)获得盐酸异丙肾上腺素注射液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2592902215","title":"华纳药厂(688799)披露拟变更注册资本及调整董事会人数,12月18日股价下跌0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592902215?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:48","pubTimestamp":1766069305,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘,华纳药厂报收于47.3元,较前一交易日下跌0.76%,最新总市值为62.11亿元。该股当日开盘47.97元,最高48.18元,最低47.2元,成交额达6566.53万元,换手率为1.05%。近日,华纳药厂发布《2025年第二次临时股东大会会议材料》公告,宣布公司拟变更注册资本、取消监事会、调整董事会人数,并修订《公司章程》办理工商变更登记。上述事项已由第四届董事会第四次会议审议通过,尚需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2590583664","title":"华纳药厂最新公告:获得硫酸镁钠钾口服用浓溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2590583664","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590583664?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:52","pubTimestamp":1765360331,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,近日收到国家药品监督管理局核准签发的硫酸镁钠钾口服用浓溶液《药品注册证书》。该药品适用于成人,用于任何需要清洁肠道的操作前的肠道清洁。华纳药厂硫酸镁钠钾口服用浓溶液按新注册分类化学药品4类获得药品注册证书,视同通过一致性评价。此药品注册证书的取得丰富了公司制剂产品品种,对优化公司产品结构有积极意义,但未来销售情况可能受多种因素影响,具有不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000028961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2586733276","title":"华纳药厂(688799)披露关于获得药品注册证书的公告,11月28日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586733276","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586733276?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:35","pubTimestamp":1764340503,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘,华纳药厂报收于48.37元,较前一交易日上涨0.62%,最新总市值为63.52亿元。该股当日开盘48.06元,最高48.66元,最低47.24元,成交额达6405.45万元,换手率为1.01%。公司近日发布公告称,湖南华纳大药厂股份有限公司收到国家药品监督管理局核准签发的富马酸福莫特罗吸入溶液《药品注册证书》。该药品适用于慢性阻塞性肺部疾病患者支气管狭窄的维持治疗,注册分类为化学药品4类,视同通过一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2586065202","title":"华纳药厂(688799.SH):富马酸福莫特罗吸入溶液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2586065202","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586065202?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:44","pubTimestamp":1764319457,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)公告,公司收到国家药品监督管理局核准签发的富马酸福莫特罗吸入溶液《药品注册证书》。富马酸福莫特罗吸入溶液用于慢性阻塞性肺部疾病(COPD)患者支气管狭窄的维持治疗,包括慢性支气管炎和肺气肿,每日两次(早上和晚上),可长期用药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2580647684","title":"每周股票复盘:华纳药厂(688799)Q3净利增198.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580647684","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580647684?lang=zh_cn&edition=full","pubTime":"2025-11-02 03:21","pubTimestamp":1762024871,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,华纳药厂报收于52.08元,较上周的50.39元上涨3.35%。本周,华纳药厂10月31日盘中最高价报53.88元。股本股东变化截至2025年9月30日,华纳药厂股东户数为6416户,较6月30日减少861户,减幅11.83%。2025年第三季度单季度营业收入3.72亿元,同比增长12.52%;归母净利润1.36亿元,同比增长198.16%;扣非净利润3968.77万元,同比下降2.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2580179974","title":"华纳药厂(688799)2025年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2580179974","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580179974?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:54","pubTimestamp":1761951253,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华纳药厂发布2025年三季报。根据财报显示,华纳药厂营收净利润同比双双增长。截至本报告期末,公司营业总收入10.86亿元,同比上升1.54%,归母净利润2.07亿元,同比上升30.75%。按单季度数据看,第三季度营业总收入3.72亿元,同比上升12.52%,第三季度归母净利润1.36亿元,同比上升198.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100008111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799"],"gpt_icon":0},{"id":"2579413451","title":"华纳药厂(688799)9月30日股东户数0.64万户,较上期减少11.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579413451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579413451?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:36","pubTimestamp":1761903370,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华纳药厂披露,截至2025年9月30日公司股东户数为6416.0户,较6月30日减少861.0户,减幅为11.83%。在化学制药行业个股中,华纳药厂股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.44万户。从股价来看,2025年6月30日至2025年9月30日,华纳药厂区间涨幅为38.45%,在此期间股东户数减少861.0户,减幅为11.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100037025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771401450556,"stockEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.1274},{"period":"6month","weight":-0.1222},{"period":"1year","weight":0.5932},{"period":"ytd","weight":-0.0497}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南华纳大药厂股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6416人(较上一季度减少11.83%)","perCapita":"20467股","listingDate":"2021-07-13","address":"湖南省长沙市浏阳市生物医药园区","registeredCapital":"13132万元","survey":" 湖南华纳大药厂股份有限公司的主营业务是化学原料药、化学药制剂和中药制剂的研发、生产与销售。公司的主要产品是制剂、原料药及中间体、植物提取物及食品。2024年,公司凭借持续的科技创新和研发投入,荣获中国证券报颁发的“新质企业金牛奖”、每日经济新闻主办的第十三届中国上市公司峰会“大健康最具成长上市公司”。","listedPrice":30.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华纳药厂,688799,华纳药厂股票,华纳药厂股票老虎,华纳药厂股票老虎国际,华纳药厂行情,华纳药厂股票行情,华纳药厂股价,华纳药厂股市,华纳药厂股票价格,华纳药厂股票交易,华纳药厂股票购买,华纳药厂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}